List of Schedule I drugs (US)
From Infogalactic: the planetary knowledge core
This is the list of Schedule I drugs as defined by the United States Controlled Substances Act.[1] The following findings are required for drugs to be placed in this schedule:[2]
- The drug or other substance has a high potential for abuse.
- The drug or other substance has no currently accepted medical use in treatment in the United States.
- There is a lack of accepted safety for use of the drug or other substance under medical supervision.
Except as specifically authorized, it is illegal for any person:
- to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance; or
- to create, distribute, or dispense, or possess with intent to distribute or dispense, a counterfeit substance.[3]
The complete list of Schedule I drugs follows.[1] The Administrative Controlled Substances Code Number for each drug is included.
Contents
Opioids
| ACSCN | Drug |
|---|---|
| 9821 | Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) |
| 9815 | Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) |
| 9601 | Acetylmethadol |
| 9602 | Allylprodine |
| 9603 | Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) |
| 9604 | Alphameprodine |
| 9605 | Alphamethadol |
| 9814 | Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) |
| 9832 | Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide) |
| 9606 | Benzethidine |
| 9607 | Betacetylmethadol |
| 9830 | Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4- piperidinyl]-N-phenylpropanamide) |
| 9831 | Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2- phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide |
| 9608 | Betameprodine |
| 9609 | Betamethadol |
| 9611 | Betaprodine |
| 9612 | Clonitazene |
| 9613 | Dextromoramide |
| 9615 | Diampromide |
| 9616 | Diethylthiambutene |
| 9168 | Difenoxin |
| 9617 | Dimenoxadol |
| 9618 | Dimepheptanol |
| 9619 | Dimethylthiambutene |
| 9621 | Dioxaphetyl butyrate |
| 9622 | Dipipanone |
| 9623 | Ethylmethylthiambutene |
| 9624 | Etonitazene |
| 9625 | Etoxeridine |
| 9626 | Furethidine |
| 9627 | Hydroxypethidine |
| 9628 | Ketobemidone |
| 9629 | Levomoramide |
| 9631 | Levophenacylmorphan |
| 9813 | 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) |
| 9833 | 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) |
| 9632 | Morpheridine |
| 9661 | MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) |
| 9633 | Noracymethadol |
| 9634 | Norlevorphanol |
| 9635 | Normethadone |
| 9636 | Norpipanone |
| 9812 | Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide |
| 9663 | PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine |
| 9637 | Phenadoxone |
| 9638 | Phenampromide |
| 9647 | Phenomorphan |
| 9641 | Phenoperidine |
| 9642 | Piritramide |
| 9643 | Proheptazine |
| 9644 | Properidine |
| 9649 | Propiram |
| 9645 | Racemoramide |
| 9835 | Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide |
| 9750 | Tilidine |
| 9646 | Trimeperidine |
Opium derivatives
Heroin powder
| ACSCN | Drug |
|---|---|
| 9319 | Acetorphine |
| 9051 | Acetyldihydrocodeine |
| 9052 | Benzylmorphine |
| 9070 | Codeine methylbromide |
| 9053 | Codeine-N-Oxide |
| 9054 | Cyprenorphine |
| 9055 | Desomorphine |
| 9145 | Dihydromorphine |
| 9335 | Drotebanol |
| 9056 | Etorphine (except hydrochloride salt) |
| 9200 | Heroin (diacetylmorphine) |
| 9301 | Hydromorphinol |
| 9302 | Methyldesorphine |
| 9304 | Methyldihydromorphine |
| 9305 | Morphine methylbromide |
| 9306 | Morphine methylsulfonate |
| 9307 | Morphine-N-Oxide |
| 9308 | Myrophine |
| 9309 | Nicocodeine |
| 9312 | Nicomorphine |
| 9313 | Normorphine |
| 9314 | Pholcodine |
| 9315 | Thebacon |
Hallucinogenic or psychedelic substances
| ACSCN | Drug |
|---|---|
| 7249 | Alpha-Ethyltryptamine (αET) |
| 7391 | 4-bromo-2,5-dimethoxy-amphetamine (DOB) |
| 7392 | 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) |
| 7396 | 2,5-dimethoxyamphetamine (DOA) |
| 7399 | 2,5-Dimethoxy-4-ethylamphetamine (DOE) |
| 7348 | 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts and salts of isomers |
| 7411 | 4-methoxyamphetamine (PMA) |
| 7401 | 5-methoxy-3,4-methylenedioxyamphetamine (MMDA) |
| 7395 | 4-methyl-2,5-dimethoxyamphetamine (DOM; STP) |
| 7400 | 3,4-methylenedioxyamphetamine (MDA) |
| 7405 | 3,4-methylenedioxymethamphetamine (MDMA) |
| 7404 | 3,4-methylenedioxy-N-ethylamphetamine (MDEA; MDE) |
| 7402 | N-hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy MDA) |
| 7390 | 3,4,5-trimethoxyamphetamine (TMA) |
| 7431 | 5-methoxy-N,N-dimethyltryptamine (5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT) |
| 7432 | Alpha-methyltryptamine (αMT) |
| 7433 | Bufotenine |
| 7434 | Diethyltryptamine (DET) |
| 7435 | Dimethyltryptamine(DMT) |
| 7439 | 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers |
| 7260 | Ibogaine |
| 7315 | Lysergic acid diethylamide (LSD) |
| 7360 | Cannabis |
| 7381 | Mescaline |
| 7374 | Parahexyl |
| 7415 | Peyote |
| 7482 | N-ethyl-3-piperidyl benzilate |
| 7484 | N-methyl-3-piperidyl benzilate |
| 7437 | Psilocybin |
| 7438 | Psilocin |
| 7370 | Tetrahydrocannabinol (THC) |
| 7455 | Ethylamine analog of phencyclidine (Eticyclidine; PCE) |
| 7458 | Pyrrolidine analog of phencyclidine (PCPy) |
| 7470 | Thiophene analog of phencyclidine (TCP) |
| 7473 | 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (TCPy) |
| 1248 | 4-methylmethcathinone (Mephedrone) |
| 7535 | 3,4-methylenedioxypyrovalerone (MDPV) |
| 7509 | 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) |
| 7508 | 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) |
| 7519 | 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) |
| 7518 | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) |
| 7385 | 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) |
| 7532 | 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) |
| 7517 | 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) |
| 7521 | 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) |
| 7524 | 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) |
| 7540 | 3,4-Methylenedioxy-N-methylcathinone (Methylone) |
| 7560 | 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) |
Depressants
gamma-Hydroxybutyrate powder
| ACSCN | Drug |
|---|---|
| 2010 | gamma-Hydroxybutyric acid (GHB; sodium oxybate; sodium oxybutyrate) |
| 2572 | Mecloqualone |
| 2565 | Methaqualone |
Stimulants
Products containing BZP.
| ACSCN | Drug |
|---|---|
| 1585 | Aminorex (aminoxaphen; 2-amino-5-phenyl-2- oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) |
| 7493 | N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine), its optical isomers, salts and salts of isomers |
| 1235 | Cathinone |
| 1503 | Fenethylline |
| 1237 | Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers |
| 1590 | (+/-)cis-4-methylaminorex |
| 1475 | N-ethylamphetamine |
| 1480 | N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) |
Cannabimimetic agents
| ACSCN | Drug |
|---|---|
| 7297 | 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) |
| 7298 | 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) |
| 7118 | 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) |
| 7173 | 1-butyl-3-(1-naphthoyl)indole (JWH-073) |
| 7019 | 1-hexyl-3-(1-naphthoyl)indole (JWH-019) |
| 7200 | 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) |
| 6250 | 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) |
| 7081 | 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081) |
| 7122 | 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) |
| 7398 | 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) |
| 7201 | 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) |
| 7694 | 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) |
| 7104 | 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4) |
| 7008 | 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole 7008 (SR-18 and RCS-8) |
| 7203 | 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) |
Temporary/emergency listings
These items are listed by the Secretary of Health and Human Services pursuant to 21 CFR 1308.49.[4][5]
| ACSCN | Drug |
|---|---|
| 7144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole) |
| 7011 | [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (5-fluoro-UR-144, 5-F-UR-144, XLR-11, 1-(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole) |
| 7048 | N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (APINACA, AKB-48) |
| 7222 | Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (QUPIC, PB-22)[6] |
| 7225 | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)[6] |
| 7012 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)[6] |
| 7035 | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA)[6] |
| 7031 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA)[7] |
| 7023 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)[7] |
| 7024 | [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)[7] |
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." />- ↑ 1.0 1.1 21 CFR 1308.11 (CSA Sched I) with changes through 77 FR 64032 (Oct 18, 2012). Retrieved September 6, 2013.
- ↑ United States Code via Cornell University's Legal Information Institute. Retrieved on 2007-10-02.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Code of Federal Regulations, 2012-04-01
- ↑ The first 8 items in the temporary section of the schedule shown on the DEA website are not included here because they are duplicates of entries in the tables above. Presumably, this is because they were made permanent and copied there at some point, but inadvertently not deleted from this temporary listing section.
- ↑ 6.0 6.1 6.2 6.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 7.0 7.1 7.2 Lua error in package.lua at line 80: module 'strict' not found.
